Literature DB >> 21594766

Minimal change disease associated with MALT lymphoma.

Rahil Kasmani1, Vamsee Priya Marina, Syed Abidi, Bikram Johar, Deepak Malhotra.   

Abstract

Low-grade Extranodal Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, a subtype of non-Hodgkin's Lymphoma, involving the kidney is a rare clinical entity. Association of Minimal change disease nephrotic range proteinuria with Hodgkin's lymphoma is well described, however is extremely uncommon with non-Hodgkin's lymphoma. We describe a patient who presented with nephrotic syndrome and a kidney biopsy revealed marginal zone lymphoma and diffuse epithelial foot process effacement. He showed dramatic response to a combination therapy with cyclophosphamide, corticosteroids, and Rituximab.

Entities:  

Mesh：

Year:  2011        PMID： 21594766     DOI： 10.1007/s11255-011-9992-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  15 in total

1.  Paraneoplastic glomerulopathies: new insights into an old entity.

Authors:  P M Ronco
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

2.  Primary MALT lymphoma of the kidney.

Authors:  M Colović; J Hadzi-Djokić; V Cemerikić; R Colović; G Janković; M Dacić
Journal:  Hematol Cell Ther       Date:  1999-11

3.  Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.

Authors:  Rodney D Gilbert; Eleanor Hulse; Susan Rigden
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

4.  Nephrotic syndrome: a prodrome to lymphoma.

Authors:  L Ghosh; R C Muehrcke
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

Review 5.  Neoplasia and glomerular injury.

Authors:  C E Alpers; R S Cotran
Journal:  Kidney Int       Date:  1986-10       Impact factor: 10.612

6.  Membranoproliferative glomerulonephritis associated with low-grade B cell lymphoma presenting in the kidney.

Authors:  M B Stokes; B Wood; Ch E Alpers
Journal:  Clin Nephrol       Date:  2002-04       Impact factor: 0.975

Review 7.  Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature.

Authors:  V Audard; F Larousserie; P Grimbert; M Abtahi; J-J Sotto; A Delmer; F Boue; D Nochy; N Brousse; R Delarue; P Remy; P Ronco; D Sahali; P Lang; O Hermine
Journal:  Kidney Int       Date:  2006-05-03       Impact factor: 10.612

Review 8.  Successful treatment of IgA nephropathy in association with low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type.

Authors:  S K Mak; P N Wong; K Y Lo; A K Wong
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

Review 9.  Epstein-Barr virus-associated high-grade B-cell lymphoma of mucosal-associated lymphoid tissue in a 9-year-old Boy.

Authors:  J Tao; L Kahn
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

10.  Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues.

Authors:  R J Pelstring; J H Essell; P J Kurtin; A R Cohen; P M Banks
Journal:  Am J Clin Pathol       Date:  1991-12       Impact factor: 2.493
View more
  3 in total

1.  Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases.

Authors:  Tomek Kofman; Shao-Yu Zhang; Christiane Copie-Bergman; Anissa Moktefi; Quentin Raimbourg; Hélène Francois; Alexandre Karras; Emmanuelle Plaisier; Bernard Painchart; Guillaume Favre; Dominique Bertrand; Emmanuel Gyan; Marc Souid; Damien Roos-Weil; Dominique Desvaux; Philippe Grimbert; Corinne Haioun; Philippe Lang; Djillali Sahali; Vincent Audard
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

2.  An unusual case of glomerulonephritis in a patient with non-Hodgkin mucosal associated lymphoid tissue (MALT) B-cell lymphoma.

Authors:  See Cheng Yeo; Khoon Leong Chuah; Hwei Yee Lee; Adrian Liew
Journal:  BMC Nephrol       Date:  2013-07-22       Impact factor: 2.388

3.  Marginal zone lymphoma causing accelerated progression of chronic kidney disease.

Authors:  Amali Samarasinghe; Daniel Wong; Gavin Cull; Aron Chakera
Journal:  BMJ Case Rep       Date:  2019-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.